What Really Matters in Early Diligence

Tue, May 12 | 02:15 PM - 02:40 PM

Session details:

  • Scientific and translational signals that predict success
  • Commercial assumptions most likely to fail
  • Aligning technical, legal, and financial diligence

Speakers:

Placeholder Headshot
Carla Bauer Director, Oncology Search and Evaluation, Business Development & Licensing Merck
Christiana Iyasere
Christiana Iyasere MD, MBA, Senior Director Technology Business Development and Accelerator Dana-Farber Cancer Institute
Elena Diez Cecilia, PhD, MBA
Elena Diez Cecilia, PhD, MBA Senior Director, External Innovation, DPDS Janssen R&D
Placeholder Headshot
Irene Blat Head of External Innovation, North America Servier
Track:
BD&L